Evidence map›Paper›PMID 37871590›Full record

Observational studyThe American journal of tropical medicine and hygiene2023

Impact of Pyrethroid Plus Piperonyl Butoxide Synergist-Treated Nets on Malaria Incidence 24 Months after a National Distribution Campaign in Rwanda.

Michee Kabera, Jean-Louis N Mangala, Radina Soebiyanto, Beata Mukarugwiro, Kaendi Munguti, Aimable Mbituyumuremyi, Naomi W Lucchi, Emmanuel Hakizimana

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in The American journal of tropical medicine and hygiene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Michee KaberaMalaria and Other Parasitic Diseases Division, Rwanda Biomedical Centre, Kigali, Rwanda.
Jean-Louis N MangalaMalaria and Other Parasitic Diseases Division, Rwanda Biomedical Centre, Kigali, Rwanda.
Radina SoebiyantoU.S. President's Malaria Initiative, U.S. Agency for International Development (USAID), Washington, District of Columbia.
Beata MukarugwiroU.S. President's Malaria Initiative, USAID, Kigali, Rwanda.
Kaendi MungutiU.S. President's Malaria Initiative, USAID, Kigali, Rwanda.
Aimable MbituyumuremyiMalaria and Other Parasitic Diseases Division, Rwanda Biomedical Centre, Kigali, Rwanda.
Naomi W LucchiU.S. President's Malaria Initiative, U.S. Centers for Disease Control and Prevention, Kigali, Rwanda.
Emmanuel HakizimanaMalaria and Other Parasitic Diseases Division, Rwanda Biomedical Centre, Kigali, Rwanda.
Rwanda Biomedical Center · RWU.S. President's Malaria Initiative · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria remains a public health priority in Rwanda. The use of insecticide-treated nets (ITNs) is a key malaria prevention tool. However, expanding pyrethroid resistance threatens the gains made in malaria control. In 2018, the Rwandan malaria program strategic approach included the use of newer types of ITNs such as pyrethroid plus piperonyl butoxide (PBO) synergist-treated nets to counter pyrethroid resistance. In February 2020, 5,892,280 ITNs were distributed countrywide; 1,085,517 of these were PBO nets distributed in five districts. This study was a pragmatic observational study that leveraged the 2020 net distribution and routinely collected confirmed malaria cases to determine the impact of PBO nets 1 and 2 years after ITN distribution. No differences were observed in the average net coverage between the PBO and standard net districts. A significant reduction in malaria incidence was reported in both the PBO (P = 0.019) and two control districts that received standard nets (P = 0.008) 1 year after ITN distribution. However, 2 years after, this reduction was sustained only in the PBO (P = 0.013) and not in the standard net districts (P = 0.685). One year after net distribution, all districts had a significant reduction in malaria incidence rate (incidence rate ratio < 1). In the second year, incidence in districts with PBO nets continued to decrease, whereas in districts with standard nets, incidences were similar to predistribution levels. The results indicate that PBO nets are a promising tool to combat pyrethroid resistance in Rwanda, with protective effects of up to 2 years post distribution.

Indexed as

InsecticidesInsecticide-Treated BednetsMalariaPyrethrinsHumansIncidenceInsecticide ResistanceMosquito ControlPiperonyl ButoxideRwandaInsecticidesPiperonyl ButoxidePyrethrins

Identifiers

PMID37871590
PMCPMC10793038
OpenAlexW4387875144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.